GTEX-1LVAO
|
61-70
|
Male
|
GTEX-1LVAO-3026 |
Pituitary gland
|
PAXgene |
1
|
1 piece; neurohypophysis outlined
|
Acceptable
|
|
GTEX-1LVAO
|
61-70
|
Male
|
GTEX-1LVAO-3126 |
Brain - cerebellum
|
PAXgene |
1
|
4 pieces
|
Acceptable
|
|
GTEX-1LVAO
|
61-70
|
Male
|
GTEX-1LVAO-3226 |
Brain - cortex
|
PAXgene |
1
|
4 pieces
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-0826 |
Lung
|
PAXgene |
1
|
2 pieces, moderate congestion/edema
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-0926 |
Liver
|
PAXgene |
1
|
2 pieces, macrovesicular steatosis in ~10% of parenchyma. Focal areas approach autolysis score 2
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-1026 |
Omentum
|
PAXgene |
1
|
2 pieces, !0-15% is interstitial fascia/mesothelial hyperplasia/vascular elements
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-1126 |
Atrial appendage
|
PAXgene |
1
|
2 pieces, focal fat necrosis
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-1226 |
Aorta
|
PAXgene |
1
|
6 pieces, adherent serosa/fat up to ~1.5mm
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-1326 |
Heart
|
PAXgene |
1
|
2 pieces, marked chronic ischemic damage, remote infarcts up to ~2.5mm, rep. ensquared
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-1626 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces, confirmed target muscularis
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-1726 |
Esophagus - muscularis
|
PAXgene |
1
|
6 pieces, confirmed target muscularis
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-2626 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces, fibroadipose elements only
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-2726 |
Brain - cortex
|
PAXgene |
1
|
4 pieces, no abnormalities
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-2826 |
Brain - cerebellum
|
PAXgene |
1
|
4 pieces (fragmented) no abnormalities
|
Acceptable
|
|
GTEX-1M4P7
|
61-70
|
Male
|
GTEX-1M4P7-2926 |
Pituitary gland
|
PAXgene |
1
|
1 piece, ~3x1mm nubbin of neurohypophysis; rest is adenohypophysis
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-0326 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; vague/early nodularity, focal cystic change
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-0426 |
Omentum
|
PAXgene |
1
|
2 pieces; mature adipose tissue, small (<10%) component of nerve and vessels
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-0526 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces; target muscularis, residual attached fat/vessels on 4 of 6
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-0626 |
Esophagus - muscularis
|
PAXgene |
1
|
6 pieces; target muscularis
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-0726 |
Esophagus - mucosa
|
PAXgene |
1
|
6 pieces
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-0926 |
Pancreas
|
PAXgene |
1
|
2 pieces; both include internal and attached fat, up to 50% in one piece, mild fibrosis
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-1026 |
Heart
|
PAXgene |
1
|
2 pieces; interstitial and focal patchy fibrosis
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-1126 |
Coronary artery
|
PAXgene |
1
|
2 pieces; one is disrupted due to calcific atherosclerosis, 2nd is 25-50% occluded with plaque and has partial rim of fat (1.5mm)
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-1226 |
Skin, leg
|
PAXgene |
1
|
6 pieces; includes up to ~10% attached and internal fat, epidermis measures
|
Acceptable
|
|
GTEX-1M5QR
|
41-50
|
Male
|
GTEX-1M5QR-1526 |
Aorta
|
PAXgene |
1
|
6 pieces; minimal plaque
|
Acceptable
|
|